APA (7th ed.) Citation

Ivashchenko, T. A., Romanenko, Y. O., Kartseva, A. S., Silkina, M. V., Mar’in, M. A., Khlyntseva, A. E., . . . Firstova, V. V. (2024). Monoclonal Antibodies Capable of Inhibiting the Interaction of the Receptor Binding Domain of SARS-CoV-2 Virus with the Angiotensin-Converting Receptor 2 of Human Cells. Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”.

Chicago Style (17th ed.) Citation

Ivashchenko, T. A., Ya. O. Romanenko, A. S. Kartseva, M. V. Silkina, M. A. Mar’in, A. E. Khlyntseva, N. A. Zeninskaya, I. G. Shemyakin, and V. V. Firstova. Monoclonal Antibodies Capable of Inhibiting the Interaction of the Receptor Binding Domain of SARS-CoV-2 Virus with the Angiotensin-Converting Receptor 2 of Human Cells. Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”, 2024.

MLA (9th ed.) Citation

Ivashchenko, T. A., et al. Monoclonal Antibodies Capable of Inhibiting the Interaction of the Receptor Binding Domain of SARS-CoV-2 Virus with the Angiotensin-Converting Receptor 2 of Human Cells. Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe”, 2024.